Mr. Moran is a seasoned commercial and operating executive with experience in both large publicly traded and private equity-backed companies. He has established a reputation as an authentic leader with the ability to set clear organizational vision while ensuring an optimal balance between strategy and execution.
Prior to joining Motus in October 2018, Mr. Moran was President of the Americas at ConvaTec, an international medical products and technologies company headquartered in the United Kingdom and was part of their Executive Committee that took the company through its initial public offering (IPO) in 2016. While at ConvaTec, Mr. Moran led the strategic design and reorganization of the America's Region, installing a new leadership team, and championing culture transformation to the organization. Prior to ConvaTec, Mr. Moran spent 18 years at Covidien, and held a number of roles with increasing responsibility in sales, marketing and general management. From 2010 to 2015, he served simultaneously as Vice President and General Manager of both the SharpSafety and Monitoring & Operating Room divisions, which had combined revenues of over $600 million at the end of his tenure. Following the 2015 acquisition of Covidien by Medtronic (NYSE:MDT), Mr. Moran was named the Vice President and General Manager of the Patient Care and Safety division, a global business generating over $1 billion in revenue at the time he left to join ConvaTec. Mr. Moran also serves as a member of the CEO Advisory Council for AdvaMed, the Advanced Medical Technology Association.
Mr. Moran received his Bachelor of Arts degree in Organizational Communication from the State University of New York at Geneseo.
With 30 years of experience in the medical device industry, Mr. Pomeranz brings a strong track record of success in both start-ups and in large multinational organizations.
Prior to joining Motus GI in 2014, Mr. Pomeranz was the founding CEO of Svelte Medical Systems. Other previous positions include serving as a Vice President at Cordis, a Johnson & Johnson company, and in senior leadership roles at Cardiac Pathways Corporations and Cardiovascular Imaging Systems, both acquired by Boston Scientific Corporation.
Mr. Pomeranz earned a MSc in Biomedical Engineering from the University of Miami, a BS in Mechanical Engineering from Union College and currently holds over 40 patents.
Mr. Taylor has over 20 years of experience serving as a financial officer, operating executive and business advisor across start-ups, emerging growth and Fortune 500 companies in both the U.S. and abroad.
Prior to joining Motus GI in August 2017, Mr. Taylor was the President and Chief Financial Officer of Angel Medical Systems, Inc., a medical device company that develops and manufactures continuous intra-cardiac ischemia monitoring and alerting systems. While at Angel Medical Systems, Mr. Taylor supervised the operations of more than fifty (50) employees in the United States and Brazil, while also overseeing the financial planning and analysis activities, capital raising efforts, and implementation of capital and operating budgets. Prior to his time at Angel Medical Systems, Mr. Taylor served as a Practice Leader for AC Lordi Consulting, a professional services firm, providing finance, accounting and strategy services. Before joining AC Lordi, Mr. Taylor was the Chief Financial Officer and Corporate Director of Operations for Safe3w, Inc., a security software company, which was acquired by iPass (NASDAQ: IPAS) in 2004.
Mr. Taylor earned a high-honors MBA with a concentration in Accounting and Finance from Northeastern University and a BA in Political Science and Economics from McGill University.
Ms. Ephrath has 20 years of medical device experience focused on managing regulatory affairs, clinical and quality assurance activities through all phases of development.
Before coming to Motus GI in 2013, Hagit Ephrath spent 11 years with Given Imaging—the world leader in capsule endoscopy. Prior to that, she worked in the blood glucose monitoring business of Carmel Biosensor.
She earned both a BA and MA in Statistics at Haifa University.
Mr. Hutchison has over 25 years of executive sales leadership and new market development experience in the medical device industry.
He most recently served as Vice President of U.S. Sales for Bio2 Medical where he was responsible for leading all commercial activities from FDA 510k clearance through national launch for market development technology for the prevention of pulmonary embolism. Prior to that, he served as Area Vice President of Sales for Medtronic GI Solutions (NYSE: MDT) where he led the Western Division of Medtronic's GI business, managed the integration of two major acquisitions and led the growth of the organization from 33 territories and 4 regions to 135 territories and 18 regions. Previously, he served as Director of U.S. Sales for BÂRRX Medical, where he led the U.S. sales organization and drove commercialization of BÂRRX's endoscopic treatment devices for Barrett's Esophagus. Mr. Hutchison was an integral part of the BÂRRX acquisition team when it was purchased in 2011 by Coviden and later acquired by Medtronic. During that time, he oversaw the hiring of 50 professionals and grew the company's domestic business by 20% over prior year, with 40% reduction in CMS reimbursement. Prior to BÂRRX, Mr. Hutchison spent 17 years at Boston Scientific (NYSE: BSX) in a variety of sales, sales management and market development roles in the endoscopy and cardiology divisions.
Mr. Hutchison holds a BS in Marketing from Bradley University and a MBA from the University of Phoenix.
James has over 30 years of cross functional Medical Device experience with the last 13 years focused on leading Quality organizations, most recently for four years as a company Quality Director in the diabetes care industry, and prior to that as managing Corporate Design Assurance at Boston Scientific.
His previous roles, at both start-ups and large organizations, have included R&D engineering, as well as leading Manufacturing & Process Development Engineering departments. This has provided both the ability to not only meet organizational Quality goals, but also partner on the engineering solutions to ensure business success.
He received a BA in Mechanical Engineering from Johnson & Wales University and his ASQ Quality Management certified as a Manager of Quality/Organizational Excellence.
Mr. Balog has extensive knowledge in product management, project management, product roadmap development, engineering, operations and production.
Prior to joining Motus GI in June 2017, Mr. Balog served as the Director of Operations and Engineering at EndoChoice. Earlier, he served as Director of Product Management at Given Imaging, Vice President of Product and Test Engineering at OptimalPlus and Product Test Engineer at Intel Fab 18. He has been granted 14 patents in the United States and has presented at various international conferences.
Mr. Balog earned his BSc in Electrical & Computer Engineering at Ben-Gurion University of the Negev.